Strengthening protections for LMICs [low and middle income countries] is not straight forward: a response to Dal-Ré and collaborators

MASTROLEO, IGNACIO

BRITISH MEDICAL JOURNAL

B M J PUBLISHING GROUP

Lugar: Londres; Año: 2014

0959-535X

This is a response to the article Dal-Ré, R., Ndebele, P., Higgs, E., Sewankambo, N., & Wendler, D. (2014). Protections for clinical trials in low and middle income countries need strengthening not weakening. BMJ, 349, g4254, http://www.bmj.com/content/349/bmj.g4254 .According to BMJ "Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window".